Trial
NCT00325741
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); City of Hope National Medical Center
Condition
Lupus Erythematosus, Systemic
Intervention
Hematopoietic Cell Transplantation
Why stopped
Difficulty with recruiting participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-15